Find clinical trials for Asthma in Budapest, Budapest
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Asthma trials near Budapest, Budapest, HUN:
12 years old with moderate to severe asthma....
Phase 2
Budapest, Hungary and 19 other locations
Primary Objective:To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a pre...
Phase 3
Budapest, Hungary and 79 other locations
to budesonide in children from 6 to less than 12 years of age with asthma.The study duration will be up to 37 weeks including an investigati...
Phase 3
Godollo, Hungary and 45 other locations
This is a study of amlitelimab for the treatment of participants with moderate-to-severe asthma. The study will have a double-blind treatmen...
Phase 2
Gödöllö, Hungary and 30 other locations
This study will assess the efficacy and safety of GSK3511294 (Depemokimab) as an adjunctive therapy in participants with severe uncontrolled asthma...
Phase 3
Gödöllő, Hungary and 141 other locations
and safety of Atuliflapon administered once daily over a 12-week treatment period to adult participants with moderate to severe uncontrolled asthma...
Phase 2
Budapest, Hungary and 350 other locations
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)
with amlitelimab in adult participants with moderate-to-severe asthma.Study details include:The study duration (per participant) will be up ...
Phase 2
Budapest, Hungary and 122 other locations
variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma...
Phase 3
Budapest, Hungary and 477 other locations
profile of GSK3511294 (Depemokimab) in participants with severe asthma with an eosinophilic phenotype following completion of clinical studi...
Phase 3
Gödöllő, Hungary and 128 other locations
decline in adult patients with uncontrolled moderate to severe asthma.The estimated duration is 4±1 weeks of screening and run-in period, fo...
Phase 4
Budapest, Hungary and 213 other locations
Clinical trials
Research sites
Resources
Legal